Evidence map›Paper›PMID 36281991›Full record

ArticleEMBO reports2022

Loss of primary cilia promotes inflammation and carcinogenesis.

Conception Paul, Ruizhi Tang, Ciro Longobardi, Rossano Lattanzio, Thibaut Eguether, Hulya Turali, Julie Bremond, Chloé Maurizy, Monica Gabola, Sophie Poupeau and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 7 institutions in 4 countries.

Conception Paul *Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
Ruizhi Tang *Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.ORCID 0000-0001-6512-845X
Ciro LongobardiInstitut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.ORCID 0000-0003-4965-9976
Rossano LattanzioDepartment of Innovative Technologies in Medicine & Dentistry, Center for Advanced Studies and Technology (CAST), 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.ORCID 0000-0001-9803-4476
Thibaut EguetherCentre de Recherche Saint Antoine, Sorbonne Université, INSERM, APHP, Paris, France.ORCID 0000-0003-1891-9253
Hulya TuraliInstitut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
Julie BremondInstitut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
Chloé MaurizyInstitut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.ORCID 0000-0002-5176-7514
Monica GabolaInstitut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
Sophie PoupeauInstitut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.
Andrei TurtoiTumor Microenvironment and Resistance to Treatment Laboratory, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.ORCID 0000-0003-3813-6635
Emilie DenicolaiCancer Research Center of Marseille (CRCM), Laboratory of Predictive Oncology, Inserm U1068 - CNRS UMR7258 - University of Aix-Marseille UM105 - Paoli Calmettes Institute (IPC), Label "Ligue contre le cancer", Marseille, France.
Maria Concetta CufaroDepartment of Innovative Technologies in Medicine & Dentistry, Center for Advanced Studies and Technology (CAST), 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.ORCID 0000-0002-6457-7795
Magali SvrcekDepartment of Pathology, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.
Philippe SeksikCentre de Recherche Saint Antoine, Sorbonne Université, INSERM, APHP, Paris, France.ORCID 0000-0003-3596-9893
Vincent CastronovoMetastasis Research Laboratory, GIGA Cancer, University of Liège, Liège, Belgium.
Philippe DelvenneCancer Research Center of Marseille (CRCM), Laboratory of Predictive Oncology, Inserm U1068 - CNRS UMR7258 - University of Aix-Marseille UM105 - Paoli Calmettes Institute (IPC), Label "Ligue contre le cancer", Marseille, France.
Vincenzo de LaurenziDepartment of Innovative Technologies in Medicine & Dentistry, Center for Advanced Studies and Technology (CAST), 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.
Quentin Da CostaCancer Research Center of Marseille (CRCM), Laboratory of Predictive Oncology, Inserm U1068 - CNRS UMR7258 - University of Aix-Marseille UM105 - Paoli Calmettes Institute (IPC), Label "Ligue contre le cancer", Marseille, France.ORCID 0000-0001-8904-9131
François BertucciCancer Research Center of Marseille (CRCM), Laboratory of Predictive Oncology, Inserm U1068 - CNRS UMR7258 - University of Aix-Marseille UM105 - Paoli Calmettes Institute (IPC), Label "Ligue contre le cancer", Marseille, France.ORCID 0000-0002-0157-0959
Bénédicte LemmersInstitut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.ORCID 0000-0002-2353-131X
Damiana PieragostinoDepartment of Innovative Technologies in Medicine & Dentistry, Center for Advanced Studies and Technology (CAST), 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.
Emilie MamessierCancer Research Center of Marseille (CRCM), Laboratory of Predictive Oncology, Inserm U1068 - CNRS UMR7258 - University of Aix-Marseille UM105 - Paoli Calmettes Institute (IPC), Label "Ligue contre le cancer", Marseille, France.ORCID 0000-0002-3516-0093
Carsten JankeInstitut Curie, Paris Sciences et Lettres (PSL) Research University, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 3348, Label "Equipe FRM", Orsay, France.ORCID 0000-0001-7053-2000
Valérie Pinet *Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.ORCID 0000-0002-4044-6440
Michael Hahne *Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Label "Equipe FRM", Montpellier, France.ORCID 0000-0002-3953-6430
Centre National de la Recherche Scientifique · FRUniversity of Chieti-Pescara · ITInserm · FRInstitut de Recherche en Cancérologie de Montpellier · FRSorbonne Université · FRUniversité Paris-Sud · FRUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cilia (PC) are important signaling hubs, and we here explored their role in colonic pathology. In the colon, PC are mostly present on fibroblasts, and exposure of mice to either chemically induced colitis-associated colon carcinogenesis (CAC) or dextran sodium sulfate (DSS)-induced acute colitis decreases PC numbers. We generated conditional knockout mice with reduced numbers of PC on colonic fibroblasts. These mice show increased susceptibility to CAC, as well as DSS-induced colitis. Secretome and immunohistochemical analyses of DSS-treated mice display an elevated production of the proinflammatory cytokine IL-6 in PC-deficient colons. An inflammatory environment diminishes PC presence in primary fibroblast cultures, which is triggered by IL-6 as identified by RNA-seq analysis together with blocking experiments. These findings suggest an activation loop between IL-6 production and PC loss. An analysis of PC presence on biopsies of patients with ulcerative colitis or colorectal cancer (CRC) reveals decreased numbers of PC on colonic fibroblasts in pathological compared with surrounding normal tissue. Taken together, we provide evidence that a decrease in colonic PC numbers promotes colitis and CRC.

Indexed as

CiliaInterleukin-6AnimalsMiceInterleukin-6colitiscolon carcinogenesiscolonic fibroblastsinflammationprimary cilia

Identifiers

PMID36281991
PMCPMC9724674
OpenAlexW4307201626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.